Kolon stock: Kolon adds TheonX Bio as subsidiary. What it means for Kolon stock

Published on 10/23/2026 at 06:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kolon added TheonX Bio as a subsidiary on October 12, 2026. Kolon stock posted KRW 1,706.70 billion revenue in the second quarter.

Corporate actions and reported figures

Kolon added TheonX Bio as a subsidiary on October 12, 2026.
Revenue reached KRW 1,706.70 billion and net income KRW 21.26 billion in the latest quarter.
Kolon Corporation paid an annual dividend of KRW 550 per share on April 3, 2026.

Kolon stock, industrials, subsidiary expansion, quarterly revenue, Korea Stock Exchange, Illustration mit AI erstellt.

Kolon added TheonX Bio as a subsidiary on October 12, 2026, according to Seoul Economic Daily. The corporate action gives the industrial group another operating entity as investors assess its latest reported figures.

What does the subsidiary add?

The October 12 disclosure identifies TheonX Bio as a new Kolon subsidiary. The announcement puts a concrete corporate-development item beside the groups operating results, while the source assigns the action to Kolon under ticker 002020.

The group financial baseline is the quarter ended June 30, 2026. Simply Wall St identifies that reporting period, while Investing.com lists revenue of KRW 1,706.70 billion and net income of KRW 21.26 billion in the latest quarterly publication dated August 14, 2026.

Three dates shape the story

On April 3, 2026, Kolon Corporation paid an annual dividend of KRW 550 per share, according to Simply Wall St.

On August 14, 2026, the companys quarterly publication listed revenue of KRW 1,706.70 billion and net income of KRW 21.26 billion. Those figures provide a dated operating reference for the October subsidiary disclosure.

On October 12, 2026, Kolon added TheonX Bio as a subsidiary, as reported by Seoul Economic Daily.

Reported figures frame the move

For investors, the subsidiary addition is best read alongside the reporting base rather than as a standalone earnings signal. Revenue of KRW 1,706.70 billion and net income of KRW 21.26 billion give the corporate action a measurable financial context, while the KRW 550 dividend shows a separate shareholder-return commitment dated April 3, 2026.

Kolon keeps a Korea listing

Kolon Corporation is listed on the Korea Stock Exchange under ticker A002020. Its reported figures and corporate actions remain tied to the groups Korean industrial structure, with the TheonX Bio addition dated October 12, 2026 as the most recent event in this account.